Description: Vipidia 12.5 mg is an oral medication used to manage blood sugar levels in adults with type 2 diabetes. It contains alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor that helps increase insulin production and decrease the amount of glucose produced by the liver. This medication is typically used in conjunction with diet and exercise to improve blood sugar control.
Ingredients:
-
Active Ingredient: Alogliptin benzoate (12.5 mg)
-
Other Ingredients: Mannitol, microcrystalline cellulose, hydroxypropyl cellulose, croscarmellose sodium, magnesium stearate, hypromellose, titanium dioxide, and ferric oxide yellow.
Usage Instructions:
- Take one tablet orally once daily.
- Can be taken with or without food.
- Swallow the tablet whole with water.
- Follow your healthcare provider's instructions regarding dosage and frequency.
- Do not skip doses or stop taking the medication without consulting your healthcare provider.
Benefits:
- Helps manage blood sugar levels in adults with type 2 diabetes.
- Increases insulin production in response to meals.
- Decreases glucose production by the liver.
- Can be used alone or in combination with other diabetes medications.
Precautions:
- Do not use if allergic to alogliptin or any other ingredients.
- Inform your healthcare provider about any other medications you are taking to avoid potential interactions.
- Use with caution in patients with kidney or liver problems.
- Not recommended for use during pregnancy or breastfeeding without medical advice.
- Possible side effects may include headache, upper respiratory tract infection, and nasopharyngitis. Seek medical attention if you experience severe side effects or signs of an allergic reaction.
- Monitor blood sugar levels regularly.
Storage Instructions:
- Store at room temperature (20°C - 25°C).
- Keep the tablets in their original packaging to protect from moisture and light.
- Keep out of reach of children.
Manufacturer:
Jazeera Pharmaceutical Industries (JPI)
